Clinical trial
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
NCT00135720 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00135720 |
|---|---|
| Title | Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris |
| Official title | A Double-Blinded, Placebo-Controlled Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Brigham and Women's Hospital Stanford University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pemphigus Vulgaris |
| Intervention type | Drug |
| Interventions | Enbrel (Etanercept) |
| Enrollment | 12 |
| Start date | Jun 1, 2004 |
| Completion | Nov 1, 2007 |
| First posted | Aug 26, 2005 |
| Last update posted | Jun 3, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: